Lorrain Daniel S.
Insider CIK 1861550 · CTNM Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CTNM Contineum Therapeutics, In | M Exercise deriv | 2026-07-09 | 2026-07-10 | 25 | — | $0 | 33,257 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise | 2026-07-09 | 2026-07-10 | 25 | $1.01 | $25 | 135,227 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-07-09 | 2026-07-10 | 25 | $16.00 | $400 | 135,202 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise deriv | 2026-07-08 | 2026-07-10 | 1,015 | — | $0 | 33,282 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-07-08 | 2026-07-10 | 1,015 | $16.00 | $16.2K | 135,202 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise | 2026-07-08 | 2026-07-10 | 1,015 | $1.01 | $1.0K | 136,217 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise deriv | 2026-07-01 | 2026-07-02 | 4,183 | — | $0 | 34,297 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise | 2026-07-01 | 2026-07-02 | 4,183 | $1.01 | $4.2K | 143,555 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-07-01 | 2026-07-02 | 5,852 | $15.67 | $91.7K | 137,703 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-07-01 | 2026-07-02 | 2,501 | $16.24 | $40.6K | 135,202 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise deriv | 2026-06-30 | 2026-07-02 | 28,826 | — | $0 | 38,480 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise | 2026-06-30 | 2026-07-02 | 28,826 | $1.01 | $29.1K | 168,198 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-06-30 | 2026-07-02 | 28,826 | $16.04 | $462.4K | 139,372 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-06-01 | 2026-06-01 | 4,170 | $13.16 | $54.9K | 139,372 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-05-01 | 2026-05-01 | 3,870 | $13.06 | $50.5K | 143,842 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-05-01 | 2026-05-01 | 300 | $13.84 | $4.2K | 143,542 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-04-06 | 2026-04-06 | 4,170 | $13.43 | $56.0K | 147,712 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-03-02 | 2026-03-02 | 4,170 | $15.01 | $62.6K | 151,882 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise deriv | 2026-02-25 | 2026-02-26 | 3,824 | — | $0 | 67,306 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise | 2026-02-25 | 2026-02-26 | 3,824 | $1.01 | $3.9K | 159,876 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-02-25 | 2026-02-26 | 3,824 | $16.01 | $61.2K | 156,052 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise deriv | 2026-02-24 | 2026-02-26 | 4,300 | — | $0 | 71,130 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-02-24 | 2026-02-26 | 4,300 | $16.03 | $68.9K | 156,052 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise | 2026-02-24 | 2026-02-26 | 4,300 | $1.01 | $4.3K | 160,352 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise deriv | 2026-02-19 | 2026-02-20 | 100 | — | $0 | 75,430 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise | 2026-02-19 | 2026-02-20 | 100 | $1.01 | $101 | 156,152 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-02-19 | 2026-02-20 | 100 | $16.00 | $1.6K | 156,052 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise deriv | 2026-02-11 | 2026-02-13 | 400 | — | $0 | 75,530 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-02-11 | 2026-02-13 | 400 | $16.00 | $6.4K | 156,052 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise | 2026-02-11 | 2026-02-13 | 400 | $1.01 | $404 | 156,452 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-02-03 | 2026-02-05 | 1,170 | $15.25 | $17.8K | 156,052 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-02-03 | 2026-02-05 | 3,000 | $14.82 | $44.5K | 157,222 | SEC↗ |
| CTNM Contineum Therapeutics, In | A Award deriv | 2026-01-30 | 2026-01-30 | 6,500 | — | $0 | 6,500 | SEC↗ |
| CTNM Contineum Therapeutics, In | A Award deriv | 2026-01-30 | 2026-01-30 | 160,000 | — | $0 | 160,000 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-01-05 | 2026-01-06 | 500 | $11.13 | $5.6K | 160,222 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-01-05 | 2026-01-06 | 3,670 | $10.35 | $38.0K | 160,722 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2025-12-23 | 2025-12-30 | 4,170 | $12.23 | $51.0K | 164,392 | SEC↗ |
| CTNM Contineum Therapeutics, In | A Award deriv | 2025-01-31 | 2025-01-31 | 110,000 | — | $0 | 110,000 | SEC↗ |
| CTNM Contineum Therapeutics, In | A Award deriv | 2025-01-31 | 2025-01-31 | 3,700 | — | $0 | 3,700 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2024-11-25 | 2024-11-27 | 1,010 | $16.02 | $16.2K | 168,562 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2024-11-18 | 2024-11-20 | 99 | $17.05 | $1.7K | 169,572 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2024-11-18 | 2024-11-20 | 6,091 | $16.37 | $99.7K | 169,671 | SEC↗ |
| CTNM Contineum Therapeutics, In | A Award deriv | 2024-05-24 | 2024-05-29 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CTNM Contineum Therapeutics, In | A Award deriv | 2024-05-24 | 2024-05-29 | 3,700 | — | $0 | 3,700 | SEC↗ |